Ketamine does not have net clinical benefit when used as an adjunct to opioids and standard coanalgesics in cancer pain.
No takes yet. Share an insight, caveat, or question.
Hardy et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: